GHK Peptide: What It Is, How It Works, and What the Evidence Shows

GHK is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) that binds copper(II) to form GHK-Cu, a signaling molecule found in human plasma, saliva, and urine [1]. In studies, GHK-Cu has been investigated as a way to signal collagen and elastin production, support wound healing, and influence genes tied to tissue repair [1][2]. It is best studied as a topical skincare ingredient; injectable and systemic forms are not FDA-approved and are available only through licensed 503A compounding pharmacies after a clinician evaluation [3].

What is the GHK peptide?

GHK is short for glycyl-L-histidyl-L-lysine — a tiny chain of three amino acids. It was first isolated from human plasma in 1973 by Dr. Loren Pickart, who noticed that a protein fraction from younger blood helped older liver tissue behave more like younger tissue in lab conditions [1]. The active piece turned out to be GHK.

GHK vs GHK-Cu (the copper complex)

GHK on its own is a signaling peptide. Its biological activity, though, comes from how tightly it binds copper(II) ions. The bound form — GHK-Cu — is what most studies use and what most skincare and compounded products contain [1]. The copper is not optional; it is part of the working molecule and is delivered into cells through the peptide.

Why GHK levels matter as you age

Your body already makes GHK. The catch is that levels fall with age. Plasma GHK drops from around 200 ng/mL in your 20s to about 80 ng/mL by age 60 [1]. Researchers have proposed that this decline may contribute to slower healing, thinner skin, and reduced collagen turnover seen with aging, though this is a hypothesis rather than a settled cause-and-effect [1].

How does GHK-Cu work in the body?

GHK-Cu is a signal peptide, not a carrier peptide. That means it tells skin cells what to do rather than just delivering an ingredient through the skin. Most of its studied action happens at fibroblasts — the cells that build the structural matrix of skin [1]. It's important to note that injectable and systemic GHK-Cu is currently being studied and is not FDA-approved for any of the uses described below.

Collagen, elastin, and glycosaminoglycan signaling

In lab and small human studies, GHK-Cu has been shown to stimulate fibroblast production of collagen, elastin, decorin (a proteoglycan that helps organize collagen fibers), and glycosaminoglycans like hyaluronic acid [1][4]. It also influences the balance of matrix metalloproteinases (MMPs) and their inhibitors, which together control how skin remodels itself [1]. Most of these data are from in-vitro or cosmetic-grade topical studies, not large randomized trials, and results don't automatically transfer to injectable use [1][4]. Reported side effects in topical studies include mild redness and irritation [4].

Wound healing and anti-inflammatory effects

GHK-Cu was first noticed because it sped up wound repair in animal models, including diabetic and steroid-suppressed wounds [1][5]. It appears to recruit immune cells and growth factors to injured tissue while modulating chronic inflammation, in part through the TGF-beta pathway [1]. Human wound-care evidence exists but is limited to small studies with medical-grade formulations [5]. GHK-Cu is not FDA-approved as a wound-care drug, and it should not be applied to open wounds without clinician direction. Reported risks include local irritation and rare contact dermatitis [4].

Gene-expression effects

A 2010 analysis using the Broad Institute's Connectivity Map reported that GHK altered expression of more than 4,000 human genes — about one-third of the protein-coding genome — generally pushing aged patterns toward a younger profile in cultured cells [2]. That breadth is part of why GHK-Cu draws so much interest, but it is also why long-term effects in living humans are not fully understood, especially for systemic use, and large randomized trials are lacking [2].

What are the benefits of GHK-Cu?

Most published human evidence is on topical GHK-Cu in cosmetic and wound-care use. Injectable and systemic use is far less studied in controlled human trials, is not FDA-approved, and is currently being investigated [3].

Skin firmness, fine lines, and tone

Small controlled cosmetic studies have reported that topical GHK-Cu creams may help with skin thickness, elasticity, and the appearance of fine lines and photodamage over 12 weeks of use [4][6]. These are cosmetic-grade studies, not drug trials, and effects are gradual and modest. Reported side effects include mild redness, itching, and rare contact dermatitis; very heavy use can leave a faint greenish tint on skin or fabrics [4].

Hair and scalp health

GHK-Cu and related copper peptides have been studied as adjuncts for hair density. In small studies they appeared to enlarge hair follicles and may extend the growth phase of the hair cycle [1][7]. Evidence is preliminary and largely from small or industry-funded cosmetic studies. Copper peptides are not FDA-approved for hair loss, and patients exploring this typically pair them with evidence-based treatments under clinician guidance. Reported side effects are mainly scalp irritation [7].

Wound and tissue repair

GHK-Cu's longest research history is in wound healing, including post-surgical sites, diabetic ulcers, and irritated skin [1][5]. Mechanism and outcome data line up most clearly here, but human trials remain small. GHK-Cu is not FDA-approved as a wound-healing drug. Local irritation, allergic reactions, and the lack of large randomized trials are the main limitations [5].

Topical GHK-Cu vs injectable GHK-Cu: what's the difference?

If you are new to copper peptides, a well-formulated topical is the most evidence-backed starting point. Injectable or compounded GHK-Cu is a separate decision that belongs in a conversation with a licensed clinician — and is an option many people also explore alongside other longevity peptides.

How long does GHK-Cu take to work?

For topical use, controlled cosmetic studies report visible changes in skin tone and texture by 8 to 12 weeks of consistent daily use [4][6]. Wound-healing effects in clinical settings can appear faster, sometimes within weeks, but that work uses medical-grade formulations under supervision and is not a basis for self-treatment [5]. Anyone expecting overnight results is likely to be disappointed — GHK-Cu appears to work by nudging the body's own repair systems, which takes time, and reported side effects such as local irritation can also take time to show up [4].

What are the side effects and risks of GHK-Cu?

Topical GHK-Cu is generally well tolerated in cosmetic studies. Reported side effects include mild redness, itching, and rare contact dermatitis [4]. Because the molecule contains copper, very heavy or layered use can leave a faint greenish tint on skin or fabrics — this is cosmetic, not dangerous [4].

Injectable GHK-Cu is currently being studied and is not FDA-approved for any indication [3]. It carries the usual risks of any injection: site pain, bruising, redness, and rare infection. Long-term safety data for systemic GHK-Cu in humans are limited [3]. People with active cancer, copper-metabolism disorders such as Wilson's disease, or significant kidney or liver disease should not use injectable GHK-Cu without specialist input. Pregnant and breastfeeding patients should avoid it because of a lack of safety data [3].

Who should — and shouldn't — consider GHK-Cu?

• May be a reasonable option: adults interested in evidence-based skin support, modest fine-line improvement, or scalp and hair health, starting with a topical formulation.
• Consider clinician guidance first: anyone considering injectable or compounded GHK-Cu, anyone with chronic skin conditions, or anyone on prescription skin therapies.
• Should avoid: people who are pregnant or breastfeeding, those with active cancer, Wilson's disease or other copper-metabolism disorders, and anyone with a known allergy to copper peptides.

How to get GHK-Cu peptide through a licensed provider

Topical GHK-Cu is sold over the counter in many serums and creams. Injectable or compounded GHK-Cu is different: it requires a prescription and is dispensed by a licensed 503A compounding pharmacy after a clinician reviews your medical history and goals [3].

A 503A compounding pharmacy prepares medications for an individual patient based on a specific prescription. This is the legal pathway in the U.S. for many peptide formulations that are not mass-manufactured FDA-approved drugs. Below is a plain-language comparison of the main paths patients use to obtain compounded GHK-Cu — including Chia — so you can see how they differ. This is not a ranking, and none of these paths should replace a clinician's individual review.

Ways patients typically access compounded GHK-Cu

Whichever path you choose, the questions to ask are the same: Is the prescriber licensed in your state? Is the pharmacy a registered 503A facility? Is there a real clinical review — including labs where indicated — before anything is dispensed? Does the pharmacy publish third-party potency and sterility testing?

GHK-Cu vs other peptides and anti-aging actives

GHK-Cu is often used alongside, not instead of, retinoids in skincare routines. Retinoids have the strongest long-term evidence for photoaging [9], while GHK-Cu adds collagen-signaling and anti-inflammatory effects with a generally gentler reported side-effect profile [4]. Readers comparing peptide options may also want to read our guides on BPC-157 and TB-500.

What peptides stack well with GHK-Cu?

In compounding-pharmacy practice and the published literature, GHK-Cu shows up alongside a few other peptides for layered skin, hair, and recovery goals. These pairings are commonly combined in clinical and research practice — they are not Chia-recommended protocols, and no combination has its own FDA-approved indication.

• GHK-Cu + BPC-157 — paired in tissue-repair and post-procedure contexts because GHK-Cu signals matrix remodeling while BPC-157 has been studied for soft-tissue recovery. Safety caveat: both modulate inflammation, and combination-specific human trials are lacking, so clinician oversight matters.
• GHK-Cu + TB-500 — sometimes combined for skin and connective-tissue support. Rationale is overlapping repair pathways. Safety caveat: TB-500 is not FDA-approved, and combined safety data are thin.
• GHK-Cu + CJC-1295 / Ipamorelin — used in longevity-oriented routines aiming at broader regenerative support. Safety caveat: stacking peptides that act on different systems compounds the unknowns and overlapping side-effect profiles; do not combine without a licensed clinician.

Frequently asked questions

Keep reading

Longevity Peptides

GHK-Cu Dosage Guide: What Patients Should Know

Longevity Peptides

TB-500 Peptide: What It Is, How It Works, and What the Research Shows

Longevity Peptides

CJC-1295 and Ipamorelin Dosage: What Patients Should Know